Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 384

1.

Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis.

van Puijvelde GH, van Es T, van Wanrooij EJ, Habets KL, de Vos P, van der Zee R, van Eden W, van Berkel TJ, Kuiper J.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2677-83. Epub 2007 Sep 27.

2.

Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.

van Puijvelde GH, Hauer AD, de Vos P, van den Heuvel R, van Herwijnen MJ, van der Zee R, van Eden W, van Berkel TJ, Kuiper J.

Circulation. 2006 Oct 31;114(18):1968-76. Epub 2006 Oct 23.

3.

Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.

Huibregtse IL, Snoeck V, de Creus A, Braat H, De Jong EC, Van Deventer SJ, Rottiers P.

Gastroenterology. 2007 Aug;133(2):517-28. Epub 2007 May 3.

PMID:
17681173
4.
5.

Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.

Zhong Y, Tang H, Wang X, Zeng Q, Liu Y, Zhao XI, Yu K, Shi H, Zhu R, Mao X.

Clin Exp Immunol. 2016 Mar;183(3):452-68. doi: 10.1111/cei.12726. Epub 2015 Nov 24.

6.

Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.

Klingenberg R, Lebens M, Hermansson A, Fredrikson GN, Strodthoff D, Rudling M, Ketelhuth DF, Gerdes N, Holmgren J, Nilsson J, Hansson GK.

Arterioscler Thromb Vasc Biol. 2010 May;30(5):946-52. doi: 10.1161/ATVBAHA.109.202671. Epub 2010 Feb 18.

7.

Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells.

Li R, Perez N, Karumuthil-Melethil S, Prabhakar BS, Holterman MJ, Vasu C.

J Immunol. 2007 Oct 15;179(8):5191-203.

8.

Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.

Sasaki N, Yamashita T, Takeda M, Shinohara M, Nakajima K, Tawa H, Usui T, Hirata K.

Circulation. 2009 Nov 17;120(20):1996-2005. doi: 10.1161/CIRCULATIONAHA.109.863431. Epub 2009 Nov 2.

9.

Establishment of nasal tolerance to heat shock protein-60 alleviates atherosclerosis by inducing TGF-β-dependent regulatory T cells.

Li H, Ding Y, Yi G, Zeng Q, Yang W.

J Huazhong Univ Sci Technolog Med Sci. 2012 Feb;32(1):24-30. doi: 10.1007/s11596-012-0004-z. Epub 2012 Jan 27.

PMID:
22282240
10.

Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.

Taleb S, Herbin O, Ait-Oufella H, Verreth W, Gourdy P, Barateau V, Merval R, Esposito B, Clément K, Holvoet P, Tedgui A, Mallat Z.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2691-8. Epub 2007 Aug 9.

11.
12.

Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.

Kang N, Tang L, Li X, Wu D, Li W, Chen X, Cui L, Ba D, He W.

Immunol Lett. 2009 Aug 15;125(2):105-13. doi: 10.1016/j.imlet.2009.06.005. Epub 2009 Jun 17.

PMID:
19539651
13.

Generation of HSP60-specific regulatory T cell and effect on atherosclerosis.

Yang K, Li D, Luo M, Hu Y.

Cell Immunol. 2006 Oct;243(2):90-5. Epub 2007 Feb 26.

PMID:
17324390
14.

Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.

Mundkur L, Mukhopadhyay R, Samson S, Varma M, Kale D, Chen D, Shivaprasad S, Sivanandan H, Soman V, Lu X, Kakkar VV.

PLoS One. 2013;8(3):e58364. doi: 10.1371/journal.pone.0058364. Epub 2013 Mar 11.

15.

Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

Transplantation. 2009 Jan 27;87(2):198-206. doi: 10.1097/TP.0b013e3181933261.

PMID:
19155973
16.
17.

Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.

Sharabi A, Lapter S, Mozes E.

J Autoimmun. 2010 Mar;34(2):87-95. doi: 10.1016/j.jaut.2009.06.002. Epub 2009 Jul 12.

PMID:
19596183
18.
19.
20.

CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice.

Zhong Y, Wang X, Ji Q, Mao X, Tang H, Yi G, Meng K, Yang X, Zeng Q.

J Clin Immunol. 2012 Oct;32(5):1104-17. doi: 10.1007/s10875-012-9699-7. Epub 2012 May 3.

PMID:
22552859

Supplemental Content

Support Center